Dear E,

I am pleased to announce the speaker lineup for the FierceBiotech Executive Breakfast & Panel Discussions during the J.P. Morgan Annual Healthcare Conference on January 14th in San Francisco. This year's event will feature a full breakfast buffet, two panel discussions, coffee break, and an Ask the Experts Closing Reception. Seats are limited and expected to sell out. Early Bird Rates end tomorrow, December 13th - click here to register and reserve your spot at the event.

Panel One / Strategic Considerations for the Commercialization of Cell and Gene Therapies:

• Dr. Mitchell Finer / Chief Scientific Officer / ElevateBio
• David J. Lennon, Ph.D. / President / AveXis, a Novartis Company
• Paul Levesque / Global President of Pfizer Rare Disease / Pfizer
• Opening Remarks: Keiko Oishi / President and COO / CMIC
• Alberto Santagostino / Head of Cell and Gene Technologies / Lonza
• Closing Remarks: Stephen J. Ubl / President and Chief Executive Officer / PhRMA
  

Panel Two / The Promise of AI: Can Artificial Intelligence and Machine Learning Really Transform R&D?

• Chris Gibson / Co-Founder and CEO / Recursion Pharmaceuticals
• Kevin Julian / Senior Managing Director, Life Sciences / Accenture
• Daphne Koller / CEO and Founder / Insitro
• Christopher McKenna / Global Head of Professional Services & Consulting / Clarivate Analytics
• Melanie Nallicheri / Life Sciences Executive, Former Chief Business Officer and Head / Biopharma, Foundation Medicine; Former SVP, Corporate Strategy and Business Development / McKesson
• Alex Zhavoronkov, PhD / Founder and CEO / Insilico Medicine

I look forward to seeing you in San Francisco.

Best,

Rebecca Willumson
Publisher
FierceBiotech & FiercePharma